Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Artrya Limited ( (AU:AYA) ) has shared an update.
Artrya Limited has secured in-principle participation from Dignity Health Arizona, part of CommonSpirit Health and one of the largest nonprofit healthcare systems in the United States, in its retrospective multi-centre SAPPHIRE Study, subject to final documentation and ethics approval. The study, set to launch in 2026, will evaluate the clinical and prognostic value of Artrya’s Salix AI-powered Plaque Analysis and proprietary Plaque Dispersion Score in identifying patients at elevated risk of cardiovascular events, with Dignity Health’s high-volume cardiovascular program expected to significantly enhance the scale and real-world relevance of the research. Artrya is also expanding the project to include SAPPHIRE-WIN, a women-only cohort focused on non-obstructive coronary artery disease, aiming to address longstanding diagnostic challenges and improve risk prediction and treatment outcomes for female patients, a group often underdiagnosed despite coronary artery disease being the leading cause of death among women globally.
The most recent analyst rating on (AU:AYA) stock is a Hold with a A$3.50 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited (ASX: AYA) is an Australian medical technology company focused on AI-powered solutions for the detection and management of coronary artery disease. Its Salix cloud platform analyses coronary CT scans to identify key biomarkers of heart disease, supporting clinicians with more accurate and efficient diagnosis. The company is pursuing regulatory and commercial expansion in key international markets as it seeks to advance cardiac care through innovative imaging and risk-stratification technologies.
Average Trading Volume: 792,094
Technical Sentiment Signal: Buy
Current Market Cap: A$558M
For a thorough assessment of AYA stock, go to TipRanks’ Stock Analysis page.